In this context, according to the largest case series reviewed in this study that compared the immunoexpression of BRAF V600E in conventional and unicystic ameloblastomas, there was also a trend indicating that unicystic types exhibit higher positivity for BRAF V600E than conventional types (8,11,13). This evidence concerns the gene BRAF and ameloblastoma.